ORE RX Trademark

Trademark Overview

On Friday, October 19, 2007, a trademark application was filed for ORE RX with the United States Patent and Trademark Office. The USPTO has given the ORE RX trademark a serial number of 77308643. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 16, 2010. This trademark is owned by Gene Logic Inc.. The ORE RX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical product evaluation, research and development
ore rx

General Information

Serial Number77308643
Word MarkORE RX
Filing DateFriday, October 19, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 16, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2009

Trademark Statements

Disclaimer with Predetermined Text"RX"
Goods and ServicesPharmaceutical product evaluation, research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 24, 2007
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameORE PHARMACEUTICALS INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameORE PHARMACEUTICALS INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressGAITHERSBURG, MD 20878
Party NameGene Logic Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Monday, August 16, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 16, 2010ABANDONMENT - NO USE STATEMENT FILED
Friday, January 15, 2010APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 15, 2010TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 14, 2010EXTENSION 1 GRANTED
Thursday, January 14, 2010EXTENSION 1 FILED
Thursday, January 14, 2010TEAS EXTENSION RECEIVED
Tuesday, July 14, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2009PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2009NOTICE OF PUBLICATION
Wednesday, March 18, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 17, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 17, 2009EXAMINER'S AMENDMENT ENTERED
Tuesday, March 17, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 17, 2009EXAMINERS AMENDMENT E-MAILED
Tuesday, March 17, 2009EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 19, 2008NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, August 19, 2008FINAL REFUSAL E-MAILED
Tuesday, August 19, 2008FINAL REFUSAL WRITTEN
Friday, August 1, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 1, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 31, 2008ASSIGNED TO LIE
Wednesday, July 30, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 2, 2008AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, January 31, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 31, 2008NON-FINAL ACTION E-MAILED
Thursday, January 31, 2008NON-FINAL ACTION WRITTEN
Wednesday, January 30, 2008ASSIGNED TO EXAMINER
Wednesday, October 24, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

development research evaluation product pharmaceutical